Wednesday, August 28, 2013

Earnings Preview: Banks, Techs, And Healthcare Report

Hot Insurance Companies To Watch In Right Now

The second quarter earnings season is well on its way and this week will be jam packed with yet another round of reports. Last week, aluminum giant Alcoa (AA) reported a $119 million second quarter loss due to weak aluminum prices, putting the bellwether's EPS at a mere 7 cents per share, but still slightly higher than Wall Street estimates. On Friday, JPMorgan (JPM) reported second quarter earnings rising 31%, while Wells Fargo & Co. (WFC) net income surged 19% . 

Below, we highlight the earnings lineup for the week ahead:

A Big Week For Big BanksInvestors should keep a close eye on financials and banking ETFs as several bellwethers post their second quarter results:

Charles Schwab (SCHW): On Tuesday, this investment bank is expected to post earnings at $0.19 per share and quarterly revenues at $1.3 billion.
Goldman Sachs Group (GS): This bellwether is expected to report an EPS of $2.82, down from the previous quarter's $4.29 reading. Revenues are also forecasted to come in lower at $8.0 billion.U.S. Bancorp (USB): EPS for this regional bank is estimated to rise to $0.76 from the previous $0.73 EPS recording. The company reports on Wednesday.The PNC Financial Services Group, Inc. (PNC): Another regional bank, PNC is expected to post earnings at $1.62 per share and revenues at $3.9 billion on Wednesday.Bank of America Corp (BAC): EPS estimates for this bellwether are around $0.26, slightly higher than the previous two quarters' $0.21 reading. Revenues are expected to dip slightly to $22.8 billion .American Express Co (AXP): On Wednesday, this credit card giant is expected to post earnings at $1.22 per share and revenues at $8.3 billion.Morgan Stanley (MS): This investment bank will report on Thursday; estimates for EPS are around $0.45 while revenues are expected to fall slightly to $7.9 billion.BB&T Corp. (BBT): Thi! s regional bank is expected to report EPS at $0.74 and revenues at $2.5 billion.Tech Reports On TapA number of tech giants will also be reporting this week; investors should keep close watch on Technology Equities and Communications Equities ETFs:

Yahoo! (YHOO): On Tuesday, this California-based tech giant is expected to post earnings at $0.30 per share and revenues at $1.1 billion.International Business Machines Corp (IBM): EPS estimates for this chip maker are around $3.80, up from the previous quarter's $3.00 reading.Intel Corp (INTC): This popular semiconductor provider is expected to report earnings at $0.40 per share and revenues at $12.9 billion.eBay, Inc (EBAY): On Wednesday, this internet retailer is slated to report EPS at $0.63 and an uptick in revenues to $3.9 billion .Verizon Communications (VZ): EPS estimates for this telecom stock are around $0.73, while revenues are expected to rise slightly to $29.8 billion.Microsoft (MSFT): On Thursday, this PC maker is expected to report a rise in earnings to $0.73 per share and revenues at $20.8 billion.Google, Inc (GOOG): This internet giant is slated to report earnings on Thursday; analysts expect EPS to come in at $10.79, lower than the previous quarter's $11.58 reading, and revenues at $14.5 billion.Healthcare Stocks To Post EarningsSeveral health & biotech companies will also be reporting:

Johnson & Johnson (JNJ): This mega-conglomerate is slated to report earnings this Tuesday. EPS is expected to come in at $1.39 and revenues at $17.7 billion.Abbott Laboratories (ABT): On Wednesday, this pharma company is expected to report earnings at $0.44 per share and revenues at $5.5 billion.UnitedHealth Group, Inc (UNH): EPS estimates for this healthcare provider are around $1.25 .Stryker Corporation (SYK): This medical equiptment maker is expected to report earnings at $1.03 per share and revenues at $2.2 billion.Consumer, Energy & Industrials ReportThe following big name companies from the consumer staples, energy,!  industr! ials sectors are reporting:

The Coca-Cola Co. (KO): This beverage behemoth is slated to report earnings on Tuesday; analysts expect EPS to come in significantly higher at $0.63, compared to the previous quarter's $0.46 reading, and revenues at $13.0 billion.Philip Morris (PM): On Thursday, this tobacco manufacturer is expected to report earnings at $1.42 per share and revenues at $8.2 billion .Schlumberger (SLB): EPS estimates for his oil equipment provider are around $1.10, while revenues are expected to come in at $11.1 billion. Honeywell International (HON): This diversified industrial giant is expected to report earnings at $1.21 per share and revenues at $9.7 billion.General Electric (GE): On Friday, this utilities company is expected to post EPS at $0.36 and revenues at $35.7 billion.Follow me on Twitter @DPylypczak.



Disclosure: No positions at time of writing.



Tuesday, August 27, 2013

Wall Street Largely Shrugs Off Weak Refining At Exxon Mobil

Not many companies can miss their quarterly EPS target by 15% and not pay a pretty steep price in the market, but then Exxon Mobil (NYSE:XOM) isn't just any company. With the downside in the second quarter coming almost entirely from the refining business, it seems like investors remain focused on the far larger (and in line) upstream exploration and production operations. Although I don't see any particular risks to the thesis that Exxon will remain an income-producing conduit for investors who want exposure to the energy space, I think a little shopping around can turn up better alternatives.

E&P Carries On
Exxon reported a 2% yoy decline in E&P production this quarter (down 7% sequentially), with liquids production basically flat. That was by and large on target versus Wall Street expectations. Operating costs continue to rise, though, and the 12% drop in unit earnings brought operating profits about 3% below sell-side estimates. On a per-barrel basis, Exxon's unit profits fell 11% to $17/boe, which continues to be better than BP (NYSE:BP), but inferior to Hess (NYSE: HES). Likewise, Exxon has running below Chevron (NYSE:CVX) of late in unit profitability, and that will likely continue this quarter.

SEE: Oil And Gas Industry Primer

If the upstream business was basically okay, the downstream operations were a total mess. Although Valero (NYSE:VLO) and Phillips 66 (NYSE:PSX) primed investors to expect more challenging conditions in refining, the 71% drop in refining profits led to a result that was only about one-quarter of the estimate. Even if you add back one-time issues like a refinery writedown, it was still a sizable and disappointing miss. Performance in the chemicals business wasn't robust either, as profits declined 8% from last year's level.

It's A Long-Term Capital Return Story
I'm not too surprised that the market is not reacting all that badly to Exxon's reported results. If anything, I would have thought the guidance for a slowdown in share repurchase activity (from about $4 billion in the second quarter and $5 billion for many quarters before that to $3 billion) would have been the bigger worry.

Be that as it may, Exxon isn't a stock to own for quarter-to-quarter wiggles. The basic thesis here remains the idea that Exxon can cost-effectively boost production by 2% to 3% across the next five years, with a variety of projects including major offshore gas developments, unconventional crude reservoirs, and various other global projects. Rising production costs are a concern, of course, but it looks like the major oil and gas companies are being much more conservative with their capital spending in this cycle – to the detriment of companies like National Oilwell Varco (NYSE:NOV).

Will Exxon's Advantages Remain So?
Exxon may boast that it thinks in decades, but the reality is that the company cannot control all of the factors that will drive its performance over the next decade. To that end, consider the refining business – although Exxon should have a relatively "advantaged" position in U.S. refining given its exposure to areas like the Mid-Continent (along with Marathon Petroleum (NYSE:MPC)), that didn't spare the company this quarter.

Likewise, being the largest North American producer of natural gas isn't so advantageous when gas prices are so low and the company can't offset it with better earnings through the chemicals business. Last and not least, it's worth remembering that while Exxon's reserve base is about 51% liquids, close to half of that is in bitumen and syncrude assets – a business that has been generating an increased negative focus in the press.

The Bottom Line
Frankly, these negatives don't strike me as serious long-term issues for Exxon. Bitumen/syncrude/tar sands may not be popular, but people want sub-$4/gallon gasoline. Likewise, I think the long-term outlook for natural gas prices is still pretty positive.

The bigger issue I have with Exxon is that I just don't think its all that cheap right now. Exxon has long enjoyed a premium multiple in the sector, but even with that factored in I think the shares are about 5% above fair value, while alternatives like Chevron and BP look considerably cheaper. If you regard Exxon as a long-term cornerstone of your portfolio, I see no reason to do anything about it, but if you're looking to add new money to the mega-cap energy space, I'd suggest Exxon may not be the best destination.

Disclosure: At the time of writing, the author did not own shares of any company mentioned in this article.


Sunday, August 25, 2013

Three Bad Omens for Stocks

The Hindenburg disaster happened over 76 years ago. But it's getting a lot of attention today...
 
The term "Hindenburg Omen" was named after the infamous 1937 crash of a German airship. Today, Wall Street uses it to describe a set of events that often occurs before the stock market crashes and burns.
 
We had three of these omens earlier this month.
 
Here's what has to happen in order to trigger a Hindenburg Omen...
 
1.   At least 2.8% of the NYSE is hitting new 52-week highs... and at least 2.8% of the NYSE is hitting new 52-week lows.
   
2.   The NYSE is higher than it was 50 days ago.
    
3.   The McClellan Oscillator is negative.
    
4.   The number of 52-week highs is not more than twice the number of new 52-week lows.
 
Once the omen is triggered, it's valid for 30 days. So if we're going to get a hard pullback in the stock market – as I've been arguing for the past couple months – then it ought to happen sometime in the next month.
 
Like most indicators, though, the omen doesn't have a perfect track record. There have been plenty of "false" signals over the past few years. And those false signals have a lot of folks dismissing the validity of last week's omens.
 
But here's the thing...
 
By itself, the Hindenburg Omen might not mean much because it triggers a lot of false signals. But when you get a cluster of Hindenburg Omen signals during a period of rising interest rates and NYSE margin levels hitting historic highs – like before the crashes in early 2000 and late 2007 – the Hindenburg Omen can be the third strike.
 
Every stock-market decline greater than 5% since 1985 has been preceded by a Hindenburg Omen. That's enough of a reason to be a little cautious right now.
 
Best regards and good trading,
 
Jeff Clark


Saturday, August 24, 2013

Palaveev: First Allied Sale Part of a ‘Second Wave’ of Investment

The announcement on Wednesday that RCAP Holdings, led by real estate investor Nicholas Schorsch, is acquiring independent broker-dealer First Allied Securities from Lovell Minnick Partners has prompted experts to debate the role of private-equity in the broker-dealer industry—particularly the independent broker-dealer field.

Philip PalaveevTo get an in-depth perspective on the subject, AdvisorOne spoke with Philip Palaveev (left), CEO of the Ensemble Practice, an advisory-practice consulting firm based in Seattle. He addressed the following questions:

Why does there seem to be so much interest by investors in broker-dealers like First Allied?  

We are seeing the investment-advisory industry, including wealth management and financial management, mature, and as it does, it’s consolidating.

You also see mergers & acquisitions when an industry is successful. By and large, consolidation is a sign of success —and that means it attracts institutional capital, because the industry needs more money from private equity, public markets and other sources.  

Broker-dealers have consolidated a lot, very heavily. First Allied was institutionally owned already, so it’s essentially going from one professional investor to another and not really changing character.

The news, though, was definitely surprising to see, but you don't have to read a lot into it. Independent broker-dealers will continue to attract the interest of investors, because it’s a very successful business, and the growth potential attracts opportunistic capital.

So, current investor interest is related to the evolution of the industry?

It’s very, very true for any industry in transition or a young industry moving to a more mature stage. That’s because as young, entrepreneurial firms grow into larger, more sizeable competitors, institutional capital steps in as owners. Lots of capital is needed for larger firms [to operate successfully], and that can’t be supplied by individual entrepreneurs.

This is true for financial advisory firms, broker-dealers, wealth-management companies—everybody. We are seeing this trend, along with consolation and institutional ownership, as larger entities need more capital. How much can a family wealth office, investment advisory firm, or other play in the financial planning industry afford? These trends are true of every player, not the just the broker-dealer industry, including RIAs and the wirehouses.

Financial planning is a young but maturing industry, and that is why we see the institutional ownership increasing, including private equity—which is a subset of institutional capital.

The industry is seen as growing and highly lucrative. The interest of private equity is a signal that this is an industry of opportunity. That’s good news—nothing else.

Are we at a particular stage in the investment cycle or history?

In terms of IBDs and their evolution, they were very small, with 100 or so advisors, and then they grew in size, scale and scope to become more successful. The insurance firms — AIG, ING, etc. — were the first to notice them.  

Now, we are seeing a much broader recognition of this business model in general versus 20 years ago, when Wall Street and its investors wouldn’t have heard much of IBDs. Today, LPL Financial (LPLA) has ads on television; Raymond James (RJF) and NFP (NFP), for instance, also are large, well-established names.

This is a second wave of investment that shows a broader recognition of the business model. In addition, the United States is experiencing a rise in private-equity investment and participation in a variety of business, like manufacturing, hotels, etc. There’s really a much broader focus, and private-equity now caters to lots of investors who own many of the best-performing companies in the United States. This—of course—means that private-equity trends will affect the broker-dealer industry.

In a healthy market, you will see changes of ownership, especially in consolidating markets. And there are not many targets remaining in the IBD space that are sizable, other than say Cambridge and Commonwealth Financial.

Keep in mind, though, institutional ownership is a reality for this industry, and it has been that way for some time.

---

Check out 7 Predictions for the Advisory Industry: Philip Palaveev on AdvisorOne.

Friday, August 23, 2013

Family Offices’ Top Concerns: Systems Security and Integration

Systems security was a chief concern of single- and multi-family office participants in a recent survey by Family Office Exchange.

Survey participants answering questions about their technology practices said another big concern was finding a software solution that integrates financial data across multiple functions.

Family offices’ sensitivity to security applied to both data and the communication of data. Seventy-one percent of participants said they did not send financial information to clients’ mobile devices.

In spite of these concerns, 56% expressed confidence in their security practices.

The FOX survey found that the desire for a reporting solution that aggregates data across key functions such as investments, tax, accounting and philanthropy remained a key challenge for family offices. Eighty-eight percent said they still relied on Excel to serve as the bridge between software packages.

Top 5 Value Companies To Invest In Right Now

“Integration remains the Holy Grail for family offices,” FOX senior consultant Jane Flanagan said in a statement.

Other key findings:

Monday, August 19, 2013

Will- A legal statement written by an individual

A 'Will' can be defined as 'a legal statement written by an individual, stating the manner in which his or her wealth may be distributed after his or her demise'. A person making a Will is known as a testator. It is best that one consults an advocate before preparing a Will. It would be better if the advocate is a person you have utmost confidence in.

Here are some guidelines to prepare a Will:

A Will should be simple, precise and clear. Otherwise there may be problems for the legal heirs. Sometimes relatives and others may try to distort the interpretation of the Will for their own benefit.

It is always better to take the advice of a trusted advocate. A Will must always be dated. If more than one Will is made then the one having the latest date will nullify all other Wills. In fact, it would be better to make a statement nullifying all other Wills or even better destroying any previously made will. There should only be one Will.

It is better to make a Will at a younger age. As and when events or incidents in the family necessitate changes, the Will can be changed. One of the advantages of making a Will at an early age is that unscrupulous relatives may contest the legality of the Will made by a very old person on the condition that the person was not of sound mind when the Will was made.

A Will can be hand-written or typed out. No stamp paper is necessary.
 
There should be an executor of the Will who would be entrusted with the responsibility of ensuring that the assets are distributed according to the provisions of the Will. Sometimes more than one executor may be required to execute the Will. The testator should take prior consent of the person whom he or she wishes to name as the executor.

A Will should be signed by the testator in the presence of at least two witnesses who have to attest the same. The full names and addresses of the witnesses should be clearly indicated in the Will. It would be better if one of the witnesses is a medical practitioner, but this is not essential. The practitioner should certify that the testator is of sound mind (especially if the testator is of an advanced age) and he or she should also note his or her registration number and degree (educational qualification). A witness should not be a beneficiary of the Will. A witness should also not be an executor of the Will.

Each page of the Will should be serially numbered and signed by the testator and the witnesses. This is to prevent substitution, replacement or insertion of a page or pages by persons with fraudulent intentions. At the end of the Will the testator can indicate the total number of pages in the Will. Corrections, if any, should be countersigned.

1 2
.gD_15nRedN{font:15px/20px Arial;color:#FF0000 !important;text-decoration:none;font-weight:normal;}

Related News

Risk-return relationship: High return is the risk premium Would falling rupee make bank FDs attractive? 
.gD_15nRed{font:15px/20px Arial;color:#FF0000 !important;text-decoration:none;font-weight:bold;}
.GoogleNewsTitle{font:14px/16px Trebuchet MS,Arial,Helvetica,sans-serif;color:#005066;text-decoration:none;} .GoogleNewsTitle:hover{text-decoration:underline} .GoogleNewsURL{font:12px Trebuchet MS,Arial,Helvetica,sans-serif;color:#000;text-decoration:none;} .GoogleNewsURL:hover{text-decoration:underline} .GoogleNewsTitleLine{font:20px/22px Trebuchet MS,Arial,Helvetica,sans-serif;color:#F01414;text-decoration:none} .GoogleNewsTitleLine:hover{text-decoration:underline} .GoogleNewsLineURL{font:12px family:Trebuchet MS,Arial,Helvetica,sans-serif;color:#000;text-decoration:none} .GoogleNewsLineURL:hover{text-decoration:underline}
Tags: Nirmal Bang, Will, Codicil, Executor, Testate, Testator, Nirmal Bang's Beyond Market
Know the finer points in clubbing income with spouse
Hilton Worldwide launches new global careers website
.scroll_hv .panel{width:250px !important; padding:10px 10px 25px !important} #scroll13{width:540px;} .hv_bx{margin-left:-10px;} .tab_data1{padding:0px;}
GET QUOTE

Sunday, August 18, 2013

CenterPoint's Gas Rate Hike OK'd - Analyst Blog

CenterPoint Energy, Inc. (CNP) won approval from the Mississippi Public Service Commission for natural gas rate hike, effective immediately. The substantial mismatch between the company's actual investment returns from modernization initiatives and allowed return drove the increase in the natural gas rate.

Per this year's rate adjustments, it was found that CenterPoint's returns were much less than its investments, resulting in the rate hike. Per the new rates, the company's residential and small commercial customers will now have to pay an extra $1.58 and $4.00 on monthly bills, respectively.

As a result of this rate increase, the minimum charge for residential customers will be $10.55 per month, up nearly 8% from $9.77. The Mississippi customers will pay 13.2 cents, up 17.8% for every 100 cubic feet of natural gas supplied for pipeline maintenance and to recoup overhead expenses.

To recuperate the cost of natural gas, additional charges included will bring the average monthly residential bill to around $34 with the average base bill rising 11% to $15.83 from $14.25.

For small commercial customers the total bill will climb to $15.09 from $13.20 with the average base bill before additional charges climbing 10.8% to $40.75. This entails customers to shell out 21 cents per 100 cubic feet reflecting an increase of 1.7 cents.

CenterPoint expects the positive rate changes to increase revenues by $2.9 million and has also agreed to utilize 55% of its asset management charges to cut gas costs by $2 million.

The company continues with its strategic investments to strengthen its infrastructure. CenterPoint Energy plans to make investments of $6.8 billion between 2013 and 2017 for maintenance and upgrade of its assets.

However, the company's modernization efforts will be put to test given the violent hurricanes predicted to hit operations in CenterPoint's service areas in the coastal regions. This along with a still fragile U.S economy will contin! ue to act as a deterrent for the company.

At the moment CenterPoint Energy has a Zacks Rank #4 (Sell). However, other utilities currently looking well positioned in the industry are Zacks Ranked #2 (Buy) DTE Energy Company (DTE), Entergy Corp. (ETR) and Calpine Corp. (CPN).

Saturday, August 17, 2013

eBay Earnings Preview: Will it Miss? - Analyst Blog

eBay Inc. (EBAY) is set to report second quarter 2013 results on Jul 17. Last quarter, it posted a 3.7% positive surprise. Let's see how things are shaping up for this announcement.

Growth Factors this Past Quarter

eBay's strength at PayPal, fast-growing presence in the mobile space and reinvigorated Marketplaces business all led to higher sales growth rates in the first quarter of 2013. The continuous introduction of new solutions to enhance the mobile shopping experience and rapid consumer adoption also contributed to higher sales.

The sale of low-value items and increased expenditure on the launch of various new products contained gross margin expansion in the last quarter.

For the second quarter, eBay expects to generate GAAP EPS of 48 to 50 cents and non GAAP EPS of 60 to 62 cents.

Earnings Whispers?

The Zacks Consensus Estimate for the second quarter stands at 54 cents per share while that for fiscal 2013 stands at $2.40.

eBay has beaten estimates in all of the last four quarters, with a trailing four-quarter average positive surprise of 5.87%.

There have been no estimate revisions in the last 30 and 60 days. As a result, the Zacks Consensus Estimate for the second quarter as well as for 2013 has remained unchanged over the same time frame. The stock carries a Zacks Rank #3 (Hold).

We caution against stocks with Zacks Ranks #4 and #5 (Sell rated stocks) going into the earnings announcement, especially when the company is seeing negative estimate revisions momentum.

Other Stocks to Consider

Our model states that a stock needs to have both a positive earnings expected surprise prediction or ESP (Read: Zacks Earnings ESP: A Better Method) and a Zacks Rank #1, #2 or #3 to beat earnings estimates. You could, therefore, consider the following stocks instead:

SanDisk Corp. (SNDK), with an ESP of +4.55% and a Zacks Rank ! #1 (Strong Buy)

Syntel Inc. (SYNT), with an ESP of +3.81% and a Zacks Rank #1 (Strong Buy)

Scientific Games Corporation (SGMS), with an ESP of +100.0% and a Zacks Rank #2 (Buy)

Friday, August 16, 2013

Perrigo Attains 52- week High - Analyst Blog

Hot Safest Companies To Own For 2014

Shares of Perrigo Company (PRGO) soared to a 52-week high of $123.95 during the second half of the trading session on Jul 5, 2013 buoyed by a series of positive developments. The closing price of the company on that day was $123.77, representing an impressive year-to-date return of 16.2%.

Moreover, Perrigo has delivered positive earnings surprises in three of the last four quarters with an average beat of 1.61%. The long-term expected earnings growth rate for this stock is 12.8%.

Acquisition of Fera's Eye-care Portfolio- A Smart Move

Last month, Perrigo purchased the ophthalmic sterile ointment and the solution product portfolio from the privately-held Fera Pharmaceuticals, for approximately $93 million in cash.

The deal, which has strengthened the company's eye-care portfolio, looks good to us. The acquisition has added nine generic prescription drugs to its portfolio. The addition of the generic prescription drugs has further strengthened the company's Rx Pharmaceuticals segment.

Perrigo expects the acquisition to boost its adjusted earnings per share in fiscal 2014 by 12 cents. The company's fiscal year ends on the last Saturday of Jun every year.

Perrigo has lately been quite active on the acquisition front. On Apr 1, 2013, the company announced that it has completed the acquisition of companion animal health company, Velcera, Inc. for approximately $160 million in cash.

In Feb 2013, the company acquired UK-based Rosemont Pharmaceuticals Ltd. By acquiring Rosemont Pharma, Perrigo has strengthened its position in the UK oral liquid formulations space.

In Dec 2012, Perrigo acquired privately held Cobrek Pharmaceuticals, Inc. for approximately $45 million in cash. In Jan 2012, the company inked a deal to acquire the assets of Georgia-based private company CanAm Care, thereby expanding its presence in ! the diabetes care market. In Jul 2011, it acquired Paddock Labs to expand its generic Rx business. We are impressed by Perrigo's growth-by-acquisition strategy.

Strong Pipeline

We are also impressed by Perrigo's strong pipeline. Perrigo has a strong pipeline and expects to launch more than 60 new products in fiscal 2013 contributing approximately $130 million to revenues.

Other Stocks to Consider

Perrigo, which develops, manufactures and distributes OTC and generic prescription pharmaceuticals, carries a Zacks Rank #3 (Hold) in the short run. Stocks such as Mylan Inc (MYL) appear to be more attractive in the generic space with a Zacks Rank #2 (Buy). Meanwhile, stocks such as Biogen Idec Inc. (BIIB) and Jazz Pharmaceuticals Public Limited Company (JAZZ) appear to be more favorably placed. Both companies carry a Zacks Rank #1 (Strong Buy) and are worth considering.

Thursday, August 15, 2013

The Actual Buying and Selling of Net-Nets

Best Low Price Stocks To Watch Right Now

The March issue of the Ben Graham Net-Net Newsletter comes out today. And while I was putting the March issue to bed, I got a trade confirmation for the newsletter's February pick.

I put in a bid for that stock on February 6 and it was filled on March 1. So – that's about a month later. This kind of waiting period is typical in net-net land. That's not the first time I've had to wait a month to get a net-net order filled. Although it is the longest the Ben Graham Net-Net Newsletter's model portfolio has had to wait for a stock.

The record won't stand. Some day it will take the newsletter more than a month to actually buy one of its picks. In fact, I'm sure a day will come when we'll be especially unlucky – and one of the newsletter's orders will simply go unfilled.

For those who don't know, the Ben Graham Net-Net Newsletter uses a real brokerage account as its model portfolio. The amount of money involved is small. Right now, the account's value is a smidge over $8,000. But it's my money. And more importantly it's real money that can only be used in real trades. Picking a net-net is one thing. Buying a net-net is another.

We don't start counting a net-net's performance once I pick it.

We only start counting a net-net's performance once it's actually in the portfolio. And we include the cost of commissions in the share price. Since the Ben Graham Net-Net Newsletter's model portfolio is a Scottrade account commissions are always $7. So, they aren't a terribly important factor in the results.

But the difficulty in acquiring shares of the newsletter's chosen net-net is a pretty big factor.

I'd like to talk about that now. Because this – more than anything – is the practical part of net-net investing that turns people off. In today's world we are used to getting things ! at a set price with the click of a button. Not just our books at Amazon. But our shares of Microsoft (MSFT) and Wells Fargo (WFC) and all the other blue chip stocks.

For those stocks, the last price you saw is pretty much the price you're going to pay. As far as the individual investor is concerned, buying Microsoft (MSFT) or Wells Fargo (WFC) isn't much different from picking a dish from a restaurant menu. You just point to the name of the thing you want and you expect your bill will have the price you saw listed.

Well it doesn't work that way with net-nets.

This frustrates new net-net investors in a couple self-destructive ways.

The Bid/Ask Spread

Some of them think the bid/ask spread – the difference between the highest price at which someone has expressed a willingness to buy shares and the lowest price at which someone has expressed a willingness to sell shares – is some sort of extra fee.

It can be. But you should never think of it that way.

I was recently talking to someone about this very issue. He wanted to know how much you should bid above the last trade price for a net-net. How far toward the ask do you need to move?

The truth is that you don't necessarily have to move toward the ask price at all. It's understandable why new net-net investors assume it's necessary to do this. And there may be times when you want to bid quite a bit more than the last trade price for a stock. (I have done this under very special circumstances.)

So part of that person's logic was sound. The more you play hard to get on price the harder it is to get your shares. That's obvious.

But the other part of his logic – that because he wanted a large number of shares relative to the amount of volume the stock normally traded he had to pay even more than most bidders – doesn't make sense.

A trade needs a buyer and a seller. The buyer wants to buy. The seller wants to sell. In an illiquid stock, the buyer is wonderi! ng how mu! ch his entrance fee will be. Meanwhile, the seller is wondering how much his exit fee will be.

If a stock normally trades 3,000 shares a day and you want to buy 30,000 shares you can quickly exhaust the supply of available sellers. That's true. Although if you watch the most illiquid stocks around – and I kind of have to as part of my job writing the Ben Graham Net-Net Newsletter – you'll notice that exhausting the supply of available sellers tends not to be the reason why you can't get the shares you want.

The reason is much simpler than that. It's Monday morning. You want to buy. Meanwhile, nobody wants to sell.

You'll see an ask price. But it's just a market maker. And it's not worth your trouble. It'll be quite a bit higher than the last trade – maybe 25 cents – and it'll only be offering you a few hundred shares at most. Ignore it.

The saddest thing you can do is just bid whatever that ask price is figuring you'll get your shares. You will. You'll get a small portion of the full amount you wanted. You'll pay something like 25 cents more than the last trade price. And anybody who is watching that stock – which up till now was probably some undiscovered gem you were hoping to keep quiet about – will now be paying closer attention to it. If a stock you know moves 5% or more – and a 25 cent move on a $5 stock is 5% – it's human nature to rubberneck.

For folks who often buy and sell illiquid stocks, seeing such a stock up or down 10% won't cause them a moment's thought once they see the volume was 100 shares. If it was 10,000 shares they may feel differently.

Regardless, if you're looking to buy shares of a stock – you want it to stay flat. You want the price flat. And you want people's feelings about it equally flat.

You don't want someone tweeting about it or blogging about it. And nothing gets people talking about a stock more than a change in price.

(It's amazing how invisible stocks bec! ome when ! they keep displaying the same price day after day.)

Invisibility is good. You want that.

Because whether you are buying or selling – you need someone on the other side of the trade. It is easiest to buy from a motivated seller. And while in liquid stocks the tumult of scary headlines and big price declines may be the great motivator – in illiquid stocks it can often be the opposite. A lack of action is what people fear. The best motivation for a seller to be accommodating on the price they're asking for an illiquid stock is the fear that they can never get out of the stock.

The seller most likely to feel that way is someone who owns many more shares than are sold in a normal month. I never talk about average daily volume figures for illiquid stocks.

Yes, websites display them.

But if you've ever checked the historical trades for some stock that's supposed to trade an average of 800 shares a day – you'll see it does nothing of the sort. It probably never trades 800 shares. It just doesn't trade most days. In fact, it's likely the stock trades closer to 5,000 shares a day but it only trades a couple days a month. Even then, you'll notice there may have been a day when it traded 80,000 shares instead of 800. That happens.

Always remember that there may be someone in a mirror image position from you. When you want to buy a lot of shares in some illiquid stock (for the very first time) – there could be someone there who has 100,000 shares of stock he's been holding for a couple years now. If he wants to sell, you can be his exit.

Most people who are new to buying and selling net-nets underestimate the difficulty of buying 500 shares in a stock that allegedly trades 1,000 shares on an average day and overestimate the difficulty of buying 10,000 shares of the same stock.

This can cause them to do some things they shouldn't. The two biggies are assuming that you simply can't get shares of some particular stock. That's sill! y. You do! n't know what you can get unless you try.

If you need 20,000 shares of a stock to make it a meaningful position in your portfolio and it only trades 1,000 shares on an average day – that's usually not a problem. At least not the problem you think it is. Now, if you want to know you can sell that position at a moment's notice – then you've got a problem.

And you shouldn't buy the stock.

But if you're looking to buy and hold something Walter Schloss style – where maybe you're hoping you'll be in and out in a year but your holding period is just as likely to end up being four years, then you're absolutely fine buying a stock like that.

In fact, other than the slight annoyance caused by putting in bids for stocks and not knowing when they'll be filled, the actual owning of illiquid stocks shouldn't be a problem for you.

There are two personal needs that make illiquid stocks a huge problem. And you need to be completely honest about these needs before deciding to delve into the world of net-nets.

1. The need for activity

2. The need for cash

You can't always foresee the second one. I know that. But, in general, try not to use your brokerage account as a source of cash. If you've ever taken money out of a brokerage account before – it's a very good idea to institute a rule that requires you to hold cash against the amount of your illiquid stocks. If you're someone who has never in your life withdrawn money from a brokerage account once you've put it in there – there's no reason you need to do this. But a little cash does make some people feel better.

I don't do it. My goal is always to be 100% invested. I was just asked about this recently and I hope to do a full article on that topic sometime soon.

The other issue is the need for activity. Or at least a tendency to trade. If you like making little changes – or big ones – to your portfolio all the time, illiquid stocks (and thus net-nets)! are prob! ably not for you.

I've said this in a lot of articles. But the toughest part of net-net investing for most people is actually holding the net-nets. The second toughest part is frustration with illiquidity (basically having to sometimes wait a month to have your orders filled). And the third hardest part is dealing with the ickiness of some net-nets.

People people to think of their net-nets as more speculative than their investments in Microsoft and Wells Fargo.

I'm not sure why that is. Microsoft and Wells Fargo are better businesses. But you also paid a lot more for them. I can understand why someone would prefer investing in Microsoft and Wells Fargo to investing in net-nets. What I can't understand is why someone would want to do both – but treat their net-nets as a less serious pursuit.

I've known some people who were really good at finding net-nets. But, sadly, they were also really good at finding reasons for selling those same net-nets too soon.

With any stock, you should at least hold it long enough for the research you did to be relevant. What I mean by that is if you bought a stock for its competitive position, good management, turnaround prospects, etc., you should at least be holding it for enough time that those things can actually have an influence on the stock's performance. Five months is not enough time for your wide moat thesis to play out.

I mentioned in my article about DreamWorks (DWA) that if I invested in that stock it would be a 25% position that I'd hold for at least three years. Some people have asked me about this wondering why the size or holding period is that important. If you like the stock and you have 15% of your portfolio in cash today, why not put 15% of your portfolio into the stock?

Good point. There's nothing wrong with doing that. But I'm not sure it fits my process. I don't like to be distracted by a lot of positions at once. I have no problem with 10% positions that are part of a group opera! tion. Hec! k, if I found 15 Japanese net-nets I loved equally, maybe I would've put 3% of my portfolio into each.

But DreamWorks is not that kind of stock. I would be buying it for its intangible assets, organization, management, etc. That's specific to the company. It's not part of a group operation. And I don't want to hold half of dozen of those kinds of things.

But the Ben Graham Net-Net Newsletter's model portfolio is about to increase to 13 stocks. And I expect it will eventually grow beyond that – simply because I won't sell many of the old net-nets and I'll keep adding a new net-net every month.

So why are the "rules" different for a net-net than they are for something like DreamWorks.

Like I said, the rule for me is that you can't just sell a stock to sell a stock. Now, yes, sometimes you find something that is truly a once-in-a-lifetime opportunity and then you can sell anything you want. You have my blessing. But other than that, you should try to – on average – at least be holding your stocks long enough for your original investment case to play out (right or wrong).

For net-nets, the investment case is simple. They're trading for less than their net current assets. I think the business would be worth more than its net current assets to a private owner. And I think the business will survive.

We can break that down into two ideas:

1. Cheap

2. Safe

The "cheap" part of the investment case for a net-net can play out (rightly) simply by the stock rising about its net current asset value. I don't mean what the NCAV was when you bought it. I mean the NCAV when you sell it.

The "safe" part of the investment case can play out (wrongly) when it's clear the company is going to go belly up.

Finally, I'm not able to handicap the safe and cheap odds on a dozen net-nets every day, week, or even month.

So, I think it makes sense to only check back in with each stock at yearly intervals. Thi! s has the! benefit of keeping me focused on picking new net-nets for the Ben Graham Net-Net Newsletter's model portfolio. Since the original selection of a stock is where you introduce the most risk into your portfolio – that's where investors should always be focused.

That means I basically have four things to check with every net-net:

1. Cheapness (Price/NCAV)

2. Safety (Bankruptcy Risk)

3. Holding Period (Annual Intervals)

4. Profit (50%+)

The last one – 50%+ profit – is a simple idea. Ben Graham liked to buy stocks at two-thirds (or less) of their NCAV and sell them when they passed NCAV. Graham's turnover was almost always below 50%. So, he held stocks for at least two years. Walter Schloss suggested his holding period averaged about four years.

I've mentioned two to five years as a range of how long you should expect to hold most net-nets. A simple calculation shows that if the Ben Graham Net-Net Newsletter is going to beat the overall market and is usually going to hold each net-net for anywhere from two to five years, it needs to sell stocks for at least 50% more than it paid for them.

This is especially true if we have losses. And we will have losses. Sometimes they'll be big ones. Hopefully, we won't have too many total losses. But we're definitely going to have losses that we need to make up for.

Of course, the idea of a 50% profit in each net-net is not exactly a criterion for selling the stock. I don't believe in setting profit targets.

But, as I sell net-nets from the Ben Graham Net-Net Newsletter's model portfolio it's important to watch how I did on each of these 4 points:

1. Was I right about the stock's cheapenss?

2. Was I right about the stock's safey?

3. How long did I end up holding the stock?

4. And did I sell the stock for at least 50% more than I bought it for?

Those four points will help us judge the newsletter's performance.

Next month, I'll ! have anot! her sell/hold decision to make – in an article everybody can read for free – and I'll have a new net-net pick for the newsletter's readers as well.

Remember: the March issue of the Ben Graham Net-Net Newsletter comes out today.

Ask Geoff a Question about the Actual Buying and Selling of Net-Nets
Check out the Ben Graham Net-Net Newsletter
Check out the Buffett/Munger Bargains Newsletter

Tuesday, August 13, 2013

SVB Financial Downgraded to Neutral - Analyst Blog

On Jul 1, we downgraded our long-term recommendation on SVB Financial Group (SIVB) to Neutral from Outperform. This was based on the persistently high operating expenses witnessed by the company.

Why the Downgrade?

Rising operating expenses remain a major concern for SVB Financial. Operating expenses have been rising mainly due to higher compensation and benefits costs. We expect expenses to mount further, owing to increased regulatory compliance costs as well as the continuous hiring of personnel.

Nevertheless, SVB Financial's first-quarter earnings marginally beat the Zacks Consensus Estimate. Results were mainly driven by growth in revenues, partially offset by a rise in operating expenses.

Over the last 90 days, the Zacks Consensus Estimate for 2013 rose 1.3% to $3.77 per share. The Zacks Consensus Estimate for 2014 fell nearly 1% to $3.97 per share, over the same time frame. Thus, SVB Financial now has a Zacks Rank #3 (Hold).

SVB Financial remains focused on its organic growth strategy, which is evident from the increase in its deposits and net interest income over the last several quarters. Further, the company aims to improve fee income as this is less susceptible to the volatility of capital markets. However, a low interest rate environment, sluggish economic recovery and stringent regulations are expected to dent the company's profitability in the near term.

Stocks That Warrant a Look

Some banks that are performing better include Central Pacific Financial Corp. (CPF), Pacific Continental Corp. (PCBK) and Umpqua Holdings Corporation (UMPQ). All of them carry a Zacks Rank #1 (Strong Buy).

Thursday, August 8, 2013

Is HP a Buy Today?

In the following video, Fool contributor Matt Thalman points out one big reason why he believes opening a new position in Hewlett-Packard (NYSE: HPQ  ) is not worth the risk today. While Matt feels that Meg Whitman has, up to this point, performed wonderfully in pulling the struggling technology company back from the edge of the cliff, the turnaround strategy still has a number of hurdles to overcome, and too many things still have to go according to plan. 

The massive wave of mobile computing has done much to unseat the major players in the PC market, including venerable technology names like Hewlett-Packard. However, HP's rapidly shifting its strategy under the new leadership of CEO Meg Whitman. But does this make HP one of the least-appreciated turnaround stories on the market, or is this a minor blip on its road to irrelevance? The Motley Fool's technology analyst details exactly what investors need to know about HP in our new premium research report. Just click here now to get your copy today.

Top 10 Energy Stocks To Own Right Now

Wednesday, August 7, 2013

Diagnosing Today's Dow Performance

The Dow Jones Industrial Average (DJINDICES: ^DJI  ) has been having a difficult time this morning deciding whether or not it wants to be up or down. This may stem from the continued confusion on behalf of investors as they try to decipher new economic data as a means to predict the Fed's stance on its current stimulus policy. Though the index dropped and rebounded a few times so far in trading, it's currently sitting at a 33-point gain just before 11:45 a.m. EDT.

Economic news
This morning investors were given mixed economic data regarding income and spending and consumer confidence. Both personal income and consumer spending were down 0.1% in April, which disappointed analysts and investors alike. Expectations were set for a 0.1% increase for income and flat spending for the month. Coupled with this morning's consumer confidence data, which is now back to pre-recession highs, the mixed data signals a disconnect in the economic recovery. Though confidence in the recovery may be high, the improvements have not yet reached the average household's billfold.

This mix of data provides just one more piece to the puzzle as investors try to find signs that the Fed will begin paring back its current stimulus plan. This week alone, investors have gotten news that unemployment figures are up, housing prices are rising, pending home sales are up, and now personal income and spending are down. This seemingly conflicting data leaves investors with little confidence as to how they should proceed in the markets.

Inside the Dow
Health-related component stocks are putting a drag on the Dow's forward momentum, with Merck (NYSE: MRK  ) being the only exception. Up 0.93% this morning, the drugmaker is enjoying the boost from its recently announced third-quarter dividend. Matching its previous payouts, the company will distribute $0.43 per share on July 8.

Procter & Gamble (NYSE: PG  ) is down 1.55% in trading, despite a resounding endorsement from activist investor Bill Ackman, who recently stated that P&G is one of the best companies in the world. Ackman's comments may have seemed like a backhanded compliment to some investors. He noted that the company is under-earning compared to its abilities, with a prediction that earnings per share will rise from $4 to $6 -- an encouraging upside. The return of A.G. Lafley to the role of CEO was initially well recieved, but investors may now be rethinking the return of a former CEO, bringing questions to light about his previous tenure and what it means for him to return.

Pfizer (NYSE: PFE  ) is down 0.91% this morning. The drug manufacturer is making more moves to clean up its operations with a sale of its Bristol, Tenn., manufacturing plant to Baltimore-based UPM Pharmaceuticals. Earlier this week, Pfizer issued $4 billion in new bonds to pay off other debts, a move not taken by the company since 2009.

Top 10 Tech Companies To Invest In Right Now

Can Merck beat the patent cliff?
This titan of the pharmaceutical industry stumbled into 2013 and continues to battle patent expirations and pipeline problems. Is Merck still a solid dividend play, or should investors be looking elsewhere? In a special premium research report on Merck, The Fool tackles all of the company's moving parts, its major market opportunities, and reasons to both buy and sell. To find out more, click here to claim your copy today.


#pitch{ margin-bottom: 15px; }
More Expert Advice from The Motley Fool
The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock in our brand-new free report: "The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just click here to access the report and find out the name of this under-the-radar company.

Can This High-Flying Retail Stock Score New Highs?

Can an apparel company that built its success on catering to women participating in a "touchy-feely" activity repeat that success by marketing to men?

Although this Canadian company has marketed its products to men since it was founded in 1998 -- and earns a surprising 12% of its revenue from that segment -- it is looking to attract men in the U.S. and overseas. However, the company had an embarrassing setback earlier this year when it was forced to recall some of its women's yoga pants because a manufacturing flaw had made them too revealing for some activities. The fiasco sent its stock price reeling to $65 in March from a high above $75 last year.

If you haven't guessed, I'm talking about Lululemon Athletica (Nasdaq: LULU).

 

The company is now looking to replace CEO Christine Day, who has been at the helm for more than five years. Lululemon's best days may still be ahead, considering that more people worldwide are becoming attuned to maintaining a healthy lifestyle. The company is also looking to grow further by appealing to the youth market and developing fabrics that provide benefits such as ultraviolet protection.

Lululemon sells casual wear and fitness apparel such as pants, tops, shorts and jackets. The company has seen its net revenue grow from $353 million in 2009 to $1.3 billion last year, up more than 250%. During this period, its earnings per share (EPS) have also grown, from 29 cents to $1.88, gaining more than 500%.

The company sells its wares through retail partners and nearly 200 of its own stores in Canada, the U.S., Australia and New Zealand. Although Lululemon sees more near-term potential in the U.S., which accounted for 61% of its profit last year, it is planning to expand overseas into other Asian and European markets, and it already has showrooms in Hong Kong and the U.K. Lululemon has also been increasing its online presence, which accounted for 14% of its net revenue last year.

For its first quarter this year, Lululemon's net revenue was up 21%, to $345 million, from the same period last year, but gross profit was up only 9% after the see-through pants fiasco. EPS for the quarter was flat at 32 cents. For its full fiscal 2013, the company anticipates that net revenue will be up more than 20% from fiscal 2012, at about $2 a share.

Lululemon's margins compare favorably with those of its competitors. Its gross margin of 55% leads those of Adidas (OTC: ADDDF) at 48%, Nike (NYSE: NKE) at 44%, and Under Armour (NYSE: UA) -- which, in contrast to Lululemon, is a male-centered brand that's now reaching out to female athletes -- at 48%. Lululemon's operating margin of 27% is also ahead of the competition.

Lululemon is on an impressive growth track, but the company also faces considerable risks. For one, consumer tastes are fickle, and nobody can say how long Lululemon's image will resonate with consumers before brand fatigue sets in. Many other well-known brands compete in this space, and others could enter.

In addition, Lululemon depends on its overseas suppliers for production and does not have any patent protection on its production processes or the materials it uses. Rising labor costs in China, where Lululemon makes more than one-third of its products, could also cut into its earnings. Not only that, but the company's earnings overseas have to be reported in U.S. dollars, and fluctuations in exchange rates for the Canadian dollar and other currencies could affect its earnings.

Risks to Consider: As a growth stock, Lululemon plows its earnings into its expansion efforts instead of paying a dividend. At a price-to-earnings ratio of nearly 40, LULU is pricey -- but long-term investors will be rewarded if the company's plans for growth take off.

Action to Take --> As the economy continues to recover, this stock, with a beta above 1.0, is also likely to outperform the overall market. The average analyst price target is $77, according to Bloomberg.

P.S. -- It's not farfetched to expect awareness of health and fitness issues to continue to rise -- but you may be surprised by our latest report, "The 11 Most Shocking Investment Predictions For 2014." Our previous predictions have given investors 89%... 92%... 293%... and even 310% gains in a year. To hear our latest, click here.

Sunday, August 4, 2013

Allscripts Healthcare Solutions Earnings Up Next

Allscripts Healthcare Solutions (Nasdaq: MDRX  ) is expected to report Q1 earnings on May 9. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Allscripts Healthcare Solutions's revenues will increase 0.8% and EPS will expand 16.7%.

The average estimate for revenue is $367.5 million. On the bottom line, the average EPS estimate is $0.14.

Revenue details
Last quarter, Allscripts Healthcare Solutions notched revenue of $350.9 million. GAAP reported sales were 9.6% lower than the prior-year quarter's $388.2 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.16. GAAP EPS were -$0.15 for Q4 against $0.14 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 38.8%, 650 basis points worse than the prior-year quarter. Operating margin was -3.6%, much worse than the prior-year quarter. Net margin was -6.9%, much worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $1.51 billion. The average EPS estimate is $0.69.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 433 members out of 462 rating the stock outperform, and 29 members rating it underperform. Among 117 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 110 give Allscripts Healthcare Solutions a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Allscripts Healthcare Solutions is hold, with an average price target of $10.90.

Is Allscripts Healthcare Solutions the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

Add Allscripts Healthcare Solutions to My Watchlist.

Saturday, August 3, 2013

S&P 500 Snapshot: A Narrow Range To Nowhere

The rally in the Nikkei 225 (up 2.32%), Shanghai Composite (up 1.55%) and Europe in general (EURO STOXX 50 up 1.47%) didn't spill over into the US. The pre-market Durable Goods report was worse than expected. The S&P 500 opened in the green but then slipped to its intraday low less than an hour later. A rally off a higher low during the lunch hour showed signs of promise, but the final hour of trading brought the index to a flat finish, up one basis point.

Here is a 10-minute look at the week so far with yesterday's narrow trading range highlighted. Only seven of the 78 market days in 2013 have had a narrower range.

(click to enlarge)

Even though the index went nowhere, it did so on 8% above average volume ... and that's without the benefit of a bogus tweet.

(click to enlarge)

The S&P 500 is now up 10.70% for 2013 and 0.92% below the all-time closing high of April 11th.

(click to enlarge)

(click to enlarge)
For a better sense of how these declines figure into a larger historical context, here's a long-term view of secular bull and bear markets in the S&P Composite since 1871.

Thursday, August 1, 2013

Carl C. Icahn and Southeastern Asset Management Issue Open Letter to Dell Stockholders and Special Committee

LET THE DESPERATE DELL DEBACLE DIE

New York, New York, July 31, 2013 – Carl C. Icahn and his affiliates and Southeastern Asset Management today issued the following open letter to stockholders of Dell (DELL) Inc. and the Dell Special Committee.

Dear Fellow Dell Stockholders and Dell Special Committee:

Today we read that the Dell Special Committee will not accept Michael Dell/Silver Lake's request to amend the stockholder approval requirement previously agreed to by Dell, Michael Dell and Silver Lake. We are pleased to see that the Special Committee heeded our advice.

But now, the Special Committee has proposed to change the record date for the special meeting of stockholders, which would further delay the stockholder vote that was first scheduled for July 18. To that proposal, we say: Enough! The stockholders have spoken – and they do not want to be frozen out by Michael Dell/Silver Lake. Let the vote happen on Friday. Michael Dell has said he is "at peace either way". We are glad to hear it! It is time to let the proposed freeze-out merger die.

If the Special Committee fails to heed our advice to hold the Special Meeting on Friday and let the stockholders finally vote after six months of uncertainty, and instead, they decide to reset the record date and schedule the Special Meeting for the fourth time, it is imperative, AS WE HAVE REQUESTED FOR MONTHS, that Dell also hold the Annual Meeting on that same day and at the same time.

LET'S MOVE FORWARD TO END THIS UNCERTAINTY

The Dell Board needs to immediately set a record date for the Annual Meeting and announce the date for the Annual Meeting. The current Dell directors have been sitting for over a year. We believe that the Dell Board has a fiduciary obligation to ensure stockholders have the opportunity to make their choice:

Do stockholders want to continue with the incumbent directors who have supported what we believe is an undervalued merger with the company's founder, largest ! stockholder and CEO?

OR

Do stockholders want to elect our director nominees who, if elected, will promptly move forward, subject to their fiduciary duties, with a Dell self-tender offer at $14 per share plus warrants and allow stockholders to remain in the company to enjoy the benefits of what we believe will be a resurgent Dell under new management?

By negotiating an undervalued freeze-out merger, pushing relentlessly to have it approved by even going so far as to try to waive one of the most important stockholder protections in the Merger Agreement, and holding an interview with The Wall Street Journal where he espouses his concern for employees and customers, but barely mentions and certainly shows no concern for, his stockholders, Michael Dell has revealed all we need to know. And to be honest, we fear to what end he will go to keep Dell under his control if and when his freeze-out merger is finally allowed to be rejected. Specifically, will he try to purchase additional stock to further increase his 15% position in the company in an attempt to ensure he keeps control of the company at the Annual Meeting? The Dell Board must consider this question seriously and should prevent Michael Dell from buying votes by buying shares. What we view as the ill-effects of Michael Dell's influence have been broadly felt. Since Michael Dell returned as CEO, the stock has dropped from $24.22, to this morning's price of $12.46. The freeze-out merger was his idea all along and it has been shown to be an unpopular one. The Board should not aid him by permitting him to increase his influence at Dell.

Again, to be very clear: Take the vote on Friday. Be "at peace" with the outcome. Immediately set the record date for the Annual Meeting and give stockholders the choice they deserve after all these months of uncertainty.

Sincerely,

Carl C. Icahn

Icahn Enterprises L.P.

O. Mason Hawkins, CFA

Southeastern Asset Management, Inc.

G. Staley Cates, CFA
So! utheastern Asset Management, Inc.